Tissue plasminogen activator in chronic subdural hematomas as a predictor of recurrence

Journal of Neurosurgery

Volumn 104, Issue 1, 2006, Pages 79-84

  Katano, Hiroyuki ^a   Kamiya, Ken ^b   Mase, Mitsuhito ^b   Tanikawa, Motoki ^b   Yamada, Kazuo ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NONE

Author keywords

Basic fibroblast growth factor; Chronic subdural hematoma; Hepatic growth factor; Recurrence; Tissue plasminogen activator; Vascular endothelial growth factor

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; FIBRINOLYTIC FACTOR; GROWTH FACTOR; PLASMIN; TISSUE PLASMINOGEN ACTIVATOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; SUBDURAL HEMATOMA;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; FIBRINOLYTIC AGENTS; HEMATOMA, SUBDURAL; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33644551865     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2006.104.1.79     Document Type: Article

References (33)

1. Frati A, Salvati M, Mainiero F, Ippoliti F, Rocchi G, Raco A, et al: Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg 100:24-32, 2004
2. Fujisawa H, Ito H, Saito K, Ikeda K, Nitta H, Yamashita J: Immunohistochemical localization of tissue-type plasminogen activator in the lining wall of chronic subdural hematoma. Surg Neurol 35:441-445, 1991
3. Hirashima Y, Endo S, Kato R, Ohmori T, Nagahori T, Nishijima M, et al: Platelet-activating factor (PAF) and the development of chronic subdural haematoma. Acta Neurochir (Wien) 129:20-25, 1994
4. Hirashima Y, Kuwayama N, Hamada H, Hayashi N, Endo S: Etizolam, an anti-anxiety agent, attenuates recurrence of chronic subdural hematoma - evaluation by computed tomography. Neurol Med Chir (Tokyo) 42:53-56, 2002
5. 2*- weighted magnetic resonance images and enlargement of the hematoma. J Neurosurg 99:824-830, 2003
6. Ito H, Saito K, Yamamoto S, Hasegawa T: Tissue-type plasminogen activator in the chronic subdural hematoma. Surg Neurol 30:175-179, 1988
7. Kawakami Y, Chikama M, Tamiya T, Shimamura Y: Coagulation and fibrinolysis in chronic subdural hematoma. Neurosurgery 25:25-29, 1989
8. Kawamoto A, Kawata H, Akai Y, Katsuyama Y, Takase E, Sasaki Y, et al: Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction. Int J Cardiol 67:47-54, 1998
9. Konig SA, Schick U, Dohnert J, Goldammer A, Vitzthum HE: Coagulopathy and outcome in patients with chronic subdural haematoma. Acta Neurol Scand 107:110-116, 2003
10. Kubo S, Takimoto H, Nakata H, Yoshimine T: Carbon dioxide insufflation for chronic subdural haematoma: a simple addition to burr-hole irrigation and closed-system drainage. Br J Neurosurg 17:547-550, 2003
11. Lind CRP, Lind CJ, Mee EW: Reduction in the number of repeated operations for the treatment of subacute and chronic subdural hematomas by placement of subdural drains. J Neurosurg 99:44-46, 2003
12. Matsumoto M, Sakata Y, Yamazaki T, Endo G, Ohishi H, Takasu N: Local coagulofibrinolysis in the postsurgical recovery of patients with chronic subdural haemotoma. Acta Neurochir (Wien) 141:177-181, 1999
13. Mochizuki R: [The role of tissue plasminogen activator in chronic subdural hematomas.] No To Shinkei 39:947-952, 1987 (Jpn)
14. Mori K, Maeda M: Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo) 41:371-381, 2001
15. Nakaguchi H, Tanishima T, Yoshimasu N: Factors in the natural history of chronic subdural hematomas that influence their post-operative recurrence. J Neurosurg 95:256-262, 2001
16. Nakajima H, Yasui T, Nishikawa M, Kishi H, Kan M: The role of postoperative patient posture in the recurrence of chronic subdural hematoma: a prospective randomized trial. Surg Neurol 58:385-387, 2002
17. Nakamura T, Nawa K, Ichikawa A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122:1450-1459, 1984
18. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, et al: Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens 14:1067-1072, 1996
19. Oishi M, Toyama M, Tamatani S, Kitazawa T, Saito M: Clinical factors of recurrent chronic subdural hematoma. Neurol Med Chir (Tokyo) 41:382-386, 2001
20. Rånby M, Bergsdorf N, Nilsson T, Mellbring G, Winblad B, Bucht G: Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin Chem 32:2160-2165, 1986
21. Saito K, Ito H, Hasegawa T, Yamamoto S: Plasmin-α2-plasmin inhibitor complex and a2-plasmin inhibitor in chronic subdural hematoma. J Neurosurg 70:68-72, 1989
22. Shiomi N, Hashimoto N, Tsujino H, Takahashi Y, Murakami M, Mineura K: [Relationship of direction of drainage tube and recurrence in chronic subdural hematoma.] No Shinkei Geka 30:823-827, 2002 (Jpn)
23. Shono T, Inamura T, Morioka T, Matsumoto K, Suzuki SO, Ikezaki K, et al: Vascular endothelial growth factor in chronic subdural haematomas. J Clin Neurosci 8:411-415, 2001
24. Sugiyama S, Yamada S, Nishikawa R, Hasebe M, Miyoshi A, Yoshizawa H, et al: [Vascular endothelial growth factor and its receptors expression in outer membrane of chronic subdural hematomas.] Jpn J Neurosurg (Tokyo) 9:796-801, 2000 (Jpn)
25. Suzuki K, Takano S, Nose T, Doi M, Ohasi N: Increased concentration of vascular endothelial growth factor (VEGF) in chronic subdural hematoma. J Trauma 46:532-533, 1999
26. Suzuki M, Kudo A, Kitakami A, Doi M, Kudo N, Kuroda K, et al: Local hypercoagulative activity precedes hyperfibrinolytic activity in the subdural space during development of chronic subdural haematoma from subdural effusion. Acta Neurochir (Wien) 140:261-266, 1998
27. Tanikawa M, Mase M, Yamada K, Yamashita N, Matsumoto T, Banno T, et al: Surgical treatment of chronic subdural hematoma based on intrahematomal membrane structure on MRI. Acta Neurochir (Wien) 143:613-619, 2001
28. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, et al: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13:1-5, 1991
29. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, et al: Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 97:381-390, 1998
30. Vaquero J, Zurita M, Cincu R: Vascular endothelial growth-permeability factor in granulation tissue of chronic subdural haematomas. Acta Neurochir (Wien) 144:343-347, 2002
31. Weigel R, Schilling L, Schmiedek P: Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease. Acta Neurochir (Wien) 143:811-819, 2001
32. Yamamoto H, Hirashima Y, Hamada H, Hayashi N, Origasa H, Endo S: Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg 98:1217-1221, 2003
33. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, et al: Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 2:821-826, 1996